Keymed Biosciences Inc. (HKG:2162)
84.25
+0.30 (0.36%)
Jul 9, 2026, 4:08 PM HKT
Keymed Biosciences Analyst Ratings
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
Unknown Analyst Shenwan Hongyuan No rating | Shenwan Hongyuan | Buy Maintains $89.47 | Buy | Maintains | $89.47 | +6.20% | May 28, 2026 |
Unknown Analyst Morgan Stanley No rating | Morgan Stanley | Buy Maintains $97.00 | Buy | Maintains | $97.00 | +15.13% | May 28, 2026 |
Unknown Analyst KeyBanc No rating | KeyBanc | Buy Maintains $87.31 | Buy | Maintains | $87.31 | +3.63% | Apr 4, 2026 |
Unknown Analyst Huatai Securities No rating | Huatai Securities | Buy Maintains $91.08 → $91.13 | Buy | Maintains | $91.08 → $91.13 | +8.17% | Mar 30, 2026 |
Unknown Analyst CLSA No rating | CLSA | Buy Maintains $78.00 | Buy | Maintains | $78.00 | -7.42% | Mar 24, 2026 |